Adaptimmune Therapeutics PLC
2021 Q4 - 2025 Q3 (16 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q3 | 11/14/2025 | 2,415 | 0.1% | 18,577,821 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 5,694 | 0.4% | 23,756,687 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 4,680 | 0.3% | 23,756,687 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 11,040 | 0.8% | 20,494,393 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 12,640 | 1.1% | 13,299,890 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 12,037 | 1.2% | 12,346,417 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 16,881 | 1.9% | 10,684,233 | 3/31/2024 |
| 2023 Q4 | 2/14/2024 | 9,585 | 1.2% | 12,086,915 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 8,551 | 1.2% | 10,963,158 | 9/30/2023 |
| 2023 Q2 | 8/14/2023 | 7,227 | 1.1% | 7,812,528 | 6/30/2023 |
| 2023 Q1 | 5/17/2023 | 5,925 | 1.0% | 5,435,439 | 3/31/2023 |
| 2022 Q4 | 2/13/2023 | 7,714 | 1.3% | 5,283,639 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 5,149 | 1.1% | 4,789,490 | 9/30/2022 |
| 2022 Q2 | 8/12/2022 | 7,955 | 1.6% | 4,679,491 | 6/30/2022 |
| 2022 Q1 | 5/13/2022 | 9,125 | 2.0% | 4,429,491 | 3/31/2022 |
| 2021 Q4 | 2/14/2022 | 8,109 | 2.2% | 2,162,313 | 12/31/2021 |